NCT01958645View on ClinicalTrials.gov

To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.

PHASE1CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy Subjects
Interventions
DRUG

MEDI8111

MEDI8111 lyophilisate for solution for infusion

OTHER

Placebo

Placebo for MEDI8111 saline solution for infusion

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY